Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 5
2012 2
2013 5
2014 11
2015 10
2016 9
2017 12
2018 10
2019 7
2020 17
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean tian lei ying (1 results)?
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. Tian X, et al. Among authors: ying t. Emerg Microbes Infect. 2020 Feb 17;9(1):382-385. doi: 10.1080/22221751.2020.1729069. eCollection 2020. Emerg Microbes Infect. 2020. PMID: 32065055 Free PMC article.
Identification of Human Single-Domain Antibodies against SARS-CoV-2.
Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, Gu C, Zhang R, Tu C, Xie Y, Yang Z, Lu L, Jiang S, Ying T. Wu Y, et al. Among authors: ying t. Cell Host Microbe. 2020 Jun 10;27(6):891-898.e5. doi: 10.1016/j.chom.2020.04.023. Epub 2020 May 14. Cell Host Microbe. 2020. PMID: 32413276 Free PMC article.
Development of Small-Molecule MERS-CoV Inhibitors.
Liang R, Wang L, Zhang N, Deng X, Su M, Su Y, Hu L, He C, Ying T, Jiang S, Yu F. Liang R, et al. Among authors: ying t. Viruses. 2018 Dec 17;10(12):721. doi: 10.3390/v10120721. Viruses. 2018. PMID: 30562987 Free PMC article. Review.
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome.
Jiang S, Xia S, Ying T, Lu L. Jiang S, et al. Among authors: ying t. Cell Mol Immunol. 2020 May;17(5):554. doi: 10.1038/s41423-020-0372-4. Epub 2020 Feb 5. Cell Mol Immunol. 2020. PMID: 32024976 Free PMC article. No abstract available.
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.
Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L. Xia S, et al. Among authors: ying t. Cell Mol Immunol. 2020 Jul;17(7):765-767. doi: 10.1038/s41423-020-0374-2. Epub 2020 Feb 11. Cell Mol Immunol. 2020. PMID: 32047258 Free PMC article. No abstract available.
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
Wan J, Xing S, Ding L, Wang Y, Gu C, Wu Y, Rong B, Li C, Wang S, Chen K, He C, Zhu D, Yuan S, Qiu C, Zhao C, Nie L, Gao Z, Jiao J, Zhang X, Wang X, Ying T, Wang H, Xie Y, Lu Y, Xu J, Lan F. Wan J, et al. Among authors: ying t. Cell Rep. 2020 Jul 21;32(3):107918. doi: 10.1016/j.celrep.2020.107918. Epub 2020 Jul 3. Cell Rep. 2020. PMID: 32668215 Free PMC article.
Human monoclonal antibodies as candidate therapeutics against emerging viruses.
Jin Y, Lei C, Hu D, Dimitrov DS, Ying T. Jin Y, et al. Among authors: ying t. Front Med. 2017 Dec;11(4):462-470. doi: 10.1007/s11684-017-0596-6. Epub 2017 Nov 20. Front Med. 2017. PMID: 29159596 Free PMC article. Review.
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
Yu F, Xiang R, Deng X, Wang L, Yu Z, Tian S, Liang R, Li Y, Ying T, Jiang S. Yu F, et al. Among authors: ying t. Signal Transduct Target Ther. 2020 Sep 22;5(1):212. doi: 10.1038/s41392-020-00318-0. Signal Transduct Target Ther. 2020. PMID: 32963228 Free PMC article. Review.
Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth.
Ma RY, Zhang H, Li XF, Zhang CB, Selli C, Tagliavini G, Lam AD, Prost S, Sims AH, Hu HY, Ying T, Wang Z, Ye Z, Pollard JW, Qian BZ. Ma RY, et al. Among authors: ying t. J Exp Med. 2020 Nov 2;217(11):e20191820. doi: 10.1084/jem.20191820. J Exp Med. 2020. PMID: 32780802
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV.
Wang L, Xu J, Kong Y, Liang R, Li W, Li J, Lu J, Dimitrov DS, Yu F, Wu Y, Ying T. Wang L, et al. Among authors: ying t. Antibodies (Basel). 2019 Nov 4;8(4):53. doi: 10.3390/antib8040053. Antibodies (Basel). 2019. PMID: 31690009 Free PMC article.
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback